Down-regulation of C/EBPα in breast cancer cells by hypoxia-estrogen combination is mainly due to hypoxia

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1227-1232

  Seifeddine, Ramzi ^a,b   Fulchignoni Lataud, Marie Claude ^a   Massaad Massade, Liliane ^b,c  

^a INSERM   (France)

^b INSERM U612   (France)

^c UMR 8121 CNRS   (France)

Author keywords

C ebp ; Estrogen; Hypoxia; T 47d cells

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; ESTROGEN; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELLULAR DISTRIBUTION; CYTOSOL; DOWN REGULATION; HYPOXIA; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION;

ANOXIA; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEINS; DOWN-REGULATION; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HALF-LIFE; HUMANS; IMMUNOENZYME TECHNIQUES; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED;

EID: 64949138996     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nerlov C: The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 17: 318-324, 2007.
2. Gery S, Tanosaki S, Bose S, Bose N, Vadgama J and Koeffler HP: Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Clin Cancer Res 11: 3184-3190, 2005.
3. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD and Tenen DG: Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res 62: 528-534, 2002.
4. Mueller BU and Pabst T: C/EBPalpha and the pathophysiology of acute myeloid leukemia. Curr Opin Hematol 13: 7-14, 2006.
5. Shim M, Powers KL, Ewing SJ, Zhu S and Smart RC: Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation. Cancer Res 65: 861-867, 2005.
6. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W and Tenen DG: Dominant- negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27: 263-270, 2001.
7. Tan EH, Hooi SC, Laban M, Wong E, Ponniah S, Wee A and Wang ND: CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma. Cancer Res 65: 10330-10337,2005.
8. Ali SH, O'Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S and Dandona P: Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res 60: 7094-7098, 2000.
9. Rahman KM and Sarkar FH: Steroid hormone mimics: molecular mechanisms of cell growth and apoptosis in normal and malignant mammary epithelial cells. J Steroid Biochem Mol Biol 80: 191-201,2002.
10. Knowles HJ and Harris AL: Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis. Breast Cancer Res 3: 318-322,2001.
11. Williams KJ, Cowen RL and Stratford IJ: Hypoxia and oxidative stress. Tumour hypoxia - therapeutic considerations. Breast Cancer Res 3: 328-331,2001.
12. Seifeddine R, Dreiem A, Tomkiewicz C, Fulchignoni-Lataud MC, Brito I, Danan JL, Favaudon V, Barouki R and Massaad- Massade L: Hypoxia and estrogen co-operate to regulate gene expression in T-47D human breast cancer cells. J Steroid Biochem Mol Biol 104: 169-179, 2007.
13. Seifeddine R, Dreiem A, Blanc E, Fulchignoni-Lataud MC, Le Frere Belda MA, Lecuru F, Mayi TH, Mazure N, Favaudon V, Massaad C, Barouki R and Massaad-Massade L: Hypoxia down- regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells. Cancer Res 68: 2158-2165, 2008.
14. Timchenko N, Wilson DR, Taylor LR, Abdelsayed S, Wilde M, Sawadogo M and Darlington GJ: Autoregulation of the human CIEBP alpha gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol 15: 1192-1202, 1995.
15. Yamaguchi Y: Microenvironmental regulation of estrogen signals in breast cancer. Breast Cancer 14: 175-181, 2007.
16. Tonini G, Schiavon G, Fratto ME, Vincenzi B and Santini D: Hormone-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions. Expert Opin Biol Ther 8: 221-234, 2008.
17. Cho J, Kim D, Lee S and Lee Y: Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia- inducible factor-lalpha in MCF-7 human breast cancer cells. Mol Endocrinol 19: 1191-1199, 2005.
18. Yeo EJ, Chun YS and Park JW: New anticancer strategies targeting HIF-1. Biochem Pharmacol 68: 1061-1069, 2004.